Egypt
Breast Cancer Diagnostics Market, 2028 is expected to grow at an impressive
rate during the forecast period, 2024-2028.
The Egypt Breast
Cancer Diagnostics Market growth is attributed to the factors such as increasing
breast cancer prevalence, the growing screening and diagnosis of breast cancer
in women, technological advancement in the testing techniques for faster
diagnosis among women in the country.
Furthermore, growing
advancement in screening techniques is influencing the market for growth as it
helps in early diagnosis and treatment of breast cancer. Also, growing awareness
of breast cancer screening, management suggestions and assessing misconceptions
play a role in utilizing relevant health services at a prior time for early
diagnosis and management of the cancer.
In the country, COVID-19
affected cancer patients regarding the availability of healthcare access, as
screenings, diagnosis, and commencement of treatment in specialized centers
were affected by the pandemic.
The disease diagnosis
was highly affected by the stages at which the breast cancer was detected and
is further subjected to treatment options in the country and is thereby driving
the breast cancer diagnostics in the country.
According to the
Globocan 2020, Egypt has total 134 632 new cases of cancer in the country.
Breast cancer being the second most prevalent type of cancer among women in the
country with 22038 new cases of cancer and holding about 32.4% of total new
cancer cases among women in the country.
Breast cancer is the
most common cancer among women in Egypt, followed by colorectal, cervical, and
ovarian cancer. The increasing incidence of cancer among women in Egypt is
attributed to several factors.
One of the main
factors contributing to the growing incidence of cancer among women in Egypt is
changes in lifestyle and diet. The adoption of a Westernized lifestyle,
including increased consumption of high-fat and processed foods, and a
sedentary lifestyle, has been linked to an increased risk of cancer. In
addition, smoking is a common risk factor for many types of cancer, and a
significant percentage of women in Egypt are smokers. According to WHO’s
Eastern Mediterranean Health Journal’s data, In 2019, Egypt has one of the
highest rates of tobacco use in the Eastern Mediterranean region, also approximately
half of Egyptian men currently smoke cigarettes or other tobacco products –
maximum of them smoke daily – compared with 0.2% of women.
Another contributing
factor is the lack of access to preventative measures and early detection
services. Many women in Egypt do not have access to regular screening programs,
and cancer is often detected at an advanced stage, which reduces the chances of
successful treatment and survival.
Other factors include
genetic predisposition, exposure to environmental toxins, and limited access to
healthcare. Environmental toxins such asbestos, vinyl chloride, benzene, radon,
and arsenic are chemicals which cause a risk for breast cancer. Women in rural
areas and those with lower socioeconomic status are at higher risk of cancer
due to limited access to healthcare.
Many organizations and
healthcare providers in the country are working to raise awareness about breast
cancer and the importance of regular screenings. This has led to an increase in
the number of women seeking screening services and has helped to detect breast
cancer at an earlier stage, when it is more treatable.
Growing Technological
Advancement In Diagnostic Tools
New imaging
techniques, such as digital mammography and breast MRI, have improved the
accuracy of breast cancer detection and have made it easier to detect breast
cancer in its early stages. These technological advancements have led to the
development of more effective treatment options, such as targeted therapies and
immunotherapy.
One such technological
advancement is digital mammography, which has become the standard method for
breast cancer screening in Egypt. Digital mammography uses computer technology
to produce high-quality images of breast tissue, making it easier for
radiologists to detect and diagnose breast cancer. This method is less
time-consuming and more accurate than traditional mammography, which uses film
to capture images.
Another technological
advancement in breast cancer diagnostics is breast MRI (magnetic resonance
imaging), which is an imaging technique that uses powerful magnets and radio
waves to create detailed images of the breast tissue. Breast MRI is used in
cases where mammography is not sufficient or where the results are
inconclusive. This method has proven to be highly effective in detecting breast
cancer in its early stages.
In addition to imaging
techniques, there have been significant advancements in molecular diagnostic
tools for breast cancer in Egypt. These tools can identify specific gene
mutations and biomarkers associated with breast cancer, allowing for more
targeted and personalized treatment options. One such tool is the Oncotype DX
test, which uses a genetic test to determine the likelihood of breast cancer
recurrence and the potential benefits of chemotherapy.
Artificial intelligence
(AI) and machine learning technologies are being increasingly used in breast
cancer diagnostics in Egypt. These technologies can help radiologists and
healthcare providers analyze large amounts of data and identify patterns and
trends that may not be immediately apparent to the human eye.
Growing Awareness Among
Women
There is a need for
increased awareness about breast cancer and the importance of early detection
and treatment in Egypt. Many organizations and healthcare providers in the
country are working to address this issue, including the Breast Cancer
Foundation of Egypt and the National Cancer Institute. These organizations
offer free or low-cost mammography screening programs and educational campaigns
to raise awareness about breast cancer and the importance of early detection.
The government has
launched several programs aimed at improving access to cancer care and
treatment, including the establishment of specialized cancer centers and the
expansion of screening programs. The government has increased funding for
cancer research, which has led to the development of new diagnostic tools and
treatment options.
According to Globocan
2020, Breast cancer is a significant
health concern in Egypt, with breast cancer being the most common cancer in
women( ~32.4%) in the country.
The country is focused on preventing,
diagnosing, treating, and managing breast cancer, with many organizations and
healthcare providers working to provide support and care to those affected by
the disease.
The Breast Cancer
Foundation of Egypt (BCFE) provides facilities such as free mammograms,
ultrasounds, and biopsies to women who cannot afford them, and provides
financial support to breast cancer patients to help cover the cost of
treatment. Similar to BCFE, there are many healthcare providers in Egypt that
specialize in breast cancer diagnosis and treatment. The National Cancer
Institute (NCI) in Cairo is one such provider, offering a range of services
including mammography, breast ultrasound, breast MRI, and breast biopsy. The
NCI provides chemotherapy, radiation therapy, and surgery for breast cancer
patients.
Another organization is
the Egyptian Society of Breast Diseases and Surgery (ESBDS). The ESBDS is a
professional organization that brings together healthcare providers who
specialize in the diagnosis and treatment of breast cancer. The ESBDS provides
education and training to its members and advocates for improved breast cancer
care in Egypt.
Moreover, access to
care can be limited for some women, particularly those living in rural areas,
and there is a shortage of trained healthcare providers and resources in many
parts of the country. There is a need for increased awareness about breast
cancer and the importance of early detection and treatment.
Download Free Sample Report
Market
Segmentation
Egypt Breast Cancer
Diagnostics Market is segmented based on the product, type, application, end
user, and region. Based on product, the market is segmented into platform-based
and instrument-based. Based on type, the market is segmented into imaging,
biopsy, genomic tests, and blood tests. Based on application, the market is
further fragmented into screening diagnostic & predictive, prognostic, and research.
Based on end-users, the market is further segmented into hospitals &
clinics, diagnostic centers, medical laboratories, and others.
Market Players
AstraZeneca, Pfizer Inc, Sanofi
, Bristol Myers Squiib, Merck & Co, Novartis AG, Eli Lilly and Company, Fresenius
Kabi, GlaxoSmithKline Egypt,GE Healthcare Egypt,
etc. are
some of the leading companies operating in the Egypt breast cancer diagnostics market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 –
2022
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2028
|
|
Quantitative Units
|
Revenue in USD Million, Volume Units and CAGR for 2018-2022
and 2023-2028
|
|
Report coverage
|
Revenue
forecast, Volume forecast company share, competitive landscape, growth
factors, and trends
|
|
Segments covered
|
Product
Application
Type
End user
|
|
Regional scope
|
Alexandria, Suze Canal, Asyut region, Delta,
Greater Cairo & Upper North Region, South upper region
|
|
Key companies profiled
|
AstraZeneca, Pfizer Inc, Sanofi , Bristol Myers Squiib, Merck
& Co, Novartis AG, Eli Lilly and Company, Fresenius Kabi, GlaxoSmithKline
Egypt, GE Healthcare Egypt
|
|
Customization scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet
your exact research needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report Scope:
In this report, Egypt Breast
Cancer Diagnostics Market, 2028, has been segmented into following categories,
in addition to the industry trends which have also been detailed below:
·
Egypt Breast Cancer Diagnostics Market, By Product
o Platform-based
o Instrument-based
·
Egypt Breast Cancer Diagnostics Market, By Type
o Imaging
o Biopsy
o Genomic Tests
o Blood Tests
·
Egypt Breast Cancer Diagnostics Market, By Application
o Screening
o Diagnostic &
Predictive
o Prognostic
o
Research
·
Egypt
Breast Cancer Diagnostics Market, By End User
o
Hospitals & Clinics
o
Diagnostic Centers
o
Medical Laboratories
o
Others
·
Egypt
Breast Cancer Diagnostics Market, By Region:
o Alexandria
o Suze Canal
o Asyut region
o Delta
o Greater Cairo & Upper North
Region
o South upper region
Competitive Landscape
Company Profiles: Detailed analysis of the
major companies present in Egypt Breast Cancer Diagnostics Market, 2028.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market
players (up to five).
Egypt Breast Cancer Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]